Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters








Language
Year range
1.
Acta cir. bras ; 29(11): 735-741, 11/2014. tab, graf
Article in English | LILACS | ID: lil-728650

ABSTRACT

PURPOSE: To evaluate intestinal inflammatory and apoptotic processes after intestinal ischemia/reperfusion injury, modulated by pentoxifylline and hypertonic saline. METHODS: It was allocated into four groups (n=6), 24 male Wistar rats (200 to 250g) and submitted to intestinal ischemia for 40 min and reperfusion for 80 min: IR (did not receive any treatment); HS group (Hypertonic Saline, 4ml/kg-IV); PTX group (Pentoxifylline, 30mg/kg-IV); HS+PTX group (Hypertonic Saline and Pentoxifylline). All animals were heparinized (100U/kg). At the end of reperfusion, ileal fragments were removed and stained on hematoxylin-eosin and histochemical studies for COX-2, Bcl-2 and cleaved caspase-3. RESULTS: The values of sO2 were higher on treated groups at 40 minutes of reperfusion (p=0.0081) and 80 minutes of reperfusion (p=0.0072). Serum lactate values were lower on treated groups after 40 minutes of reperfusion (p=0.0003) and 80 minutes of reperfusion (p=0.0098). Morphologic tissue injuries showed higher grades on IR group versus other groups: HS (p=0.0006), PTX (p=0.0433) and HS+PTX (p=0.0040). The histochemical study showed lesser expression of COX-2 (p=0.0015) and Bcl-2 (p=0.0012) on HS+PTX group. A lower expression of cleaved caspase-3 was demonstrated in PTX (p=0.0090; PTXvsIR). CONCLUSION: The combined use of pentoxifylline and hypertonic saline offers best results on inflammatory and apoptotic inhibitory aspects after intestinal ischemia/reperfusion. .


Subject(s)
Animals , Male , Apoptosis/drug effects , Intestines/blood supply , Ischemia/complications , Pentoxifylline/pharmacology , Phosphodiesterase Inhibitors/pharmacology , Reperfusion Injury/prevention & control , Saline Solution, Hypertonic/pharmacology , /analysis , /analysis , Immunohistochemistry , Intestines/drug effects , Ischemia/prevention & control , Lactic Acid/blood , Oxygen/metabolism , Pentoxifylline/therapeutic use , Phosphodiesterase Inhibitors/therapeutic use , Rats, Wistar , Reference Values , Reproducibility of Results , Reperfusion Injury/blood , Saline Solution, Hypertonic/therapeutic use , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL